Supreme Court Decides Bruesewitz v. Wyeth 6-2, Foreclosing Civil Lawsuits for Vaccine Design Defect Supporting organizations support the overall mission and intent of CVS, but press releases are only endorsed by those organizations that have individually signed on and do not necessarily reflect the views or endorsement of all CVS members. Contact: Mary Holland, Esq., […]
Gardasil vaccination: Evaluating the risks versus benefits
Natural News
Wednesday, February 23, 2011
by: Rosemary Mathis, Director of SANE VAX, INC.
All drugs are associated with some risks of adverse reactions and vaccines are no exception. In weighing risks versus benefits, one has to keep in mind that vaccines represent a special category of drugs since they are generally given to healthy individuals. If there are uncertain benefits from a vaccine, only a small level of risk of harmful effects may be acceptable. If the benefits are certain, then a greater risk of side effects may be tolerated. Here I review the current evidence which indicates that the former case applies to Gardasil, the quadrivalent human papillomavirus (qHPV) vaccine:
SaneVax Introduces One More Gardasil Girl: Sara from Utah
SANE Vax, Inc.
HPV vaccines are among the most expensive vaccines on the market. No one knows if they will decrease the rate of cervical cancer; no one knows how many adverse reactions people have endured. Sara is one. When do the risks outweigh the benefits?
FOR IMMEDIATE RELEASE
PRLog (Press Release) – Feb 22, 2011 – At 19 years old, Sara had everything going for her. She was attending Brigham Young University on a full academic scholarship, majoring in Social Work with a minor in women’s studies. In addition to being academically gifted, she had been a dancer for years. She was in excellent health, never smoked or drank alcohol, ate healthy food and exercised regularly. She was a virgin. In short, she was at very minimal risk for cervical cancer.
Turning cervical cancer into an infectious disease
Natural News Tuesday, February 22, 2011 by: Rosemary Mathis, Director of SANE VAX, INC. In February of 2010, an article appeared in J Epidemiol Community Health titled: “Assessing the effectiveness of human papillomavirus (HPV) vaccination to prevent cervical cancer: perspectives from Germany” blatantly refers to converting cervical cancer from a oncological disease into an infectious […]
Merck Funded Study States – Gardasil Equally Effective for Males and Females
SANE Vax, Inc. is Concerned about Missing Data in the Reports FOR IMMEDIATE RELEASE PRLog (Press Release) – Feb 21, 2011 – The media went wild last week announcing the report published in the Feb. 3 issue of the New England Journal of Medicine, (NEJM) was funded by the vaccine’s maker, Merck & Co., 1 […]
- « Previous Page
- 1
- …
- 40
- 41
- 42
- 43
- 44
- …
- 51
- Next Page »
